- STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckleyEli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its neuroscience pipeline.STAT · 9d ago↗ source
- Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckleyEli Lilly said on Thursday it will buy psychedelic drug developer AtaiBeckley for $2.8 billion upfront, in a move that further spotlights big pharma’s increasing interest in the space after years o…Endpoints · 9d ago↗ source
- STAT+: Spring forward forever? Another daylight saving debate arrives in CongressTrump's pandemic preparedness nominee testifies, the "fang-to-pharmacy" pipeline, and more health news from Morning RoundsSTAT